Prof. Constantinos Zamboglou
Prof. Constantinos Zamboglou
eC1jb3JlZGF0YTovLzY5MDU5NkE5LThDNEItNDk3RC1BNTgxLUMzMjU4RENDQjdBNC9GaWxlL3AzNA==

Professor Constantinos Zamboglou, PhD, MHBA, studied medicine in Freiburg, Germany, until 2013. In this period, he completed his doctoral thesis at the laboratory of Prof. Aktories with the grade summa cum laude. He was resident in the Department of Radiation Oncology at the University of Freiburg, Germany. In 2019 he obtained his board licence and in 2020 his postdoctoral lecture qualification. From 2019-2020 he worked as senior consultant, where he was responsible for the treatment of patients suffering from genito-urethral cancer. In 2021 he also became the section head of the Department of Interventional Radiotherapy. Since 2022 he is the Deputy Medical Director at the German Medical Institute in Limassol. He published over 100 research articles in renown and peer-reviewed journals and in 2020 he received the “Herman-Holthusen” Award of the German Society of Radiation Oncology. Since 2021 he is an invited member of the German prostate cancer expert panel and since 2023, he is a member of the ESTRO focus group for genito-urethral cancer. For his research he received funding for over 8 million euro focusing on state-of-art clinical trials and implementation of innovative health-technology for patient-centred care.

Education/Academic Experience

09 / 2004 – 07 / 2006  Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008 Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013   Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012  Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, GermanyDoctoral thesis, grade: summa cum laude

05 / 2018   Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center – University of Freiburg

01 / 2019   Board certification: Radiotherapy and Radiation Oncology

03 / 2020  Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23 MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022  Completion of ISO 9001:2015 training, Nicosia, Cyprus



Clinical Application

09 / 2013 – 01 / 2019  Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020 Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019 Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022 Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022 Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022 German Medical Institute, Limassol, Cyprus, Vice Medical Director



Honors + Awards

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”



People Say

“No two diseases and no two patients are alike. Thanks to personalized therapy planning, we move away from a one-size-fits-all approach to treatment”

Prof. Constantinos Zamboglou

Make an Appointment